As money-raisers, 2004 #146;s initial offerings fall short When Inhibitex Inc. set the terms of its initial public offering in March, it thought it was being conservative, expecting shares to sell for \$10 to \$12 apiece. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 